A time and motion analysis: potential costs savings associated with a 72-hour intravenous infusion of pantoprazole using the new 24-hour stable solution

Author： Mueller Tanja   Barkun Alan N.  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.3, 2007-03, pp. : 20-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NCIC CTG IND.181: Phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignancies

By Dent S.   Gelmon K.   Chi K.   Jonker D.   Wainman N.   Capier C.   Chen E.   Lyons J.   Seymour L.  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1522-1529

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of Paclitaxel Administered As a 3-Hour or 96-Hour Infusion

By Panday V.R.N.A.N.N.A.N.   Huinink W.W.T.E.N.B.O.K.K.E.L.   Vermorken J.B.   Rosing H.   Koopman F.J.   Swart M.   Schellens J.H.M.   Beijnen J.H.  

Pharmacological Research, Vol. 40, Iss. 1, 1999-07 ,pp. : 67-74

Academic Press

Access to resources Recommend Favorite

Population Pharmacokinetic Model Characterizing 24‐Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 8, 2015-08 ,pp. : 454-464

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy

By Ramanathan Ramesh  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1591-1596

Springer Publishing Company

Access to resources Recommend Favorite

A Flexible Daily Dosage Regimen of Oxaprozin Potassium in Patients with Acute Knee Pain Associated with Osteoarthritis: 24-Hour Analgesic Durability and Safety

By Kivitz A.J.  

Clinical Drug Investigation, Vol. 21, Iss. 11, 2001-11 ,pp. : 745-753

Adis International

Access to resources Recommend Favorite